| Literature DB >> 33802594 |
Federico Zappaterra1, Stefania Costa1, Daniela Summa1, Valerio Bertolasi2, Bruno Semeraro3, Paola Pedrini1, Raissa Buzzi1, Silvia Vertuani4.
Abstract
Cortisone is a steroid widely used as an anti-inflammatory drug able to suppress the immune system, thus reducing inflammation and attendant pain and swelling at the site of an injury. Due to its numerous side effects, especially in prolonged and high-dose therapies, the development of the pharmaceutical industry is currently aimed at finding new compounds with similar activities but with minor or no side effects. Biotransformations are an important methodology towards more sustainable industrial processes, according to the principles of "green chemistry". In this work, the biotransformation of cortisone with Rhodococcus rhodnii DSM 43960 to give two new steroids, i.e., 1,9β,17,21-tetrahydoxy-4-methyl-19-nor-9β-pregna-1,3,5(10)-trien-11,20-dione and 1,9β,17,20β,21-pentahydoxy-4-methyl-19-nor-9β-pregna-1,3,5(10)-trien-11-one, is reported. These new steroids have been fully characterized.Entities:
Keywords: Rhodococcus rhodnii; biotransformation; cortisone; steroids
Year: 2021 PMID: 33802594 PMCID: PMC7962003 DOI: 10.3390/molecules26051352
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411